.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Haryana government recently launched a pioneering active TB screening model to identify infections before symptoms surface. Specifically, this initiative integrates corporate funding with artificial intelligence to revolutionize diagnostic accuracy. Announced during World TB Week, the project involves a Rs 20.5 crore partnership with the BPCL Foundation. This strategic shift moves the state away from passive reporting toward proactive identification. Consequently, healthcare providers can now intervene earlier in the disease cycle to improve patient outcomes.
Additionally, the state will deploy 150 Truenat Quattro molecular diagnostic machines to enhance testing at the grassroots level. These portable devices provide rapid, gold-standard results in remote areas. Therefore, health workers can significantly reduce the critical delays between sample collection and confirmed diagnosis. This intervention targets 2,111 high-risk villages and urban wards to ensure maximum impact. Furthermore, the administration plans to conduct 15 lakh sputum tests this year to maintain high surveillance standards.
Moreover, health officials have introduced AI-powered handheld X-ray devices to screen individuals in vulnerable zones. These advanced tools identify lung abnormalities even in asymptomatic patients, shifting the focus toward pre-emptive care. To ensure total coverage, 65 Mobile Medical Units and dedicated Ni-Kshay Vahans will reach underserved populations. This doorstep delivery of healthcare effectively bypasses common barriers like geography and social stigma. Ultimately, the government aims for a TB-free Haryana where no patient remains undetected due to lack of access.
Q1: How does the new model improve TB detection in Haryana?
The model uses AI-enabled handheld X-ray devices to identify lung abnormalities in asymptomatic individuals, allowing for earlier medical intervention before symptoms appear.
Q2: What is the significance of the partnership with the BPCL Foundation?
A Rs 20.5 crore partnership provides 150 Truenat Quattro molecular diagnostic machines, which significantly boosts rapid testing capacity at the community level.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Haryana's new TB model uses AI-enabled X-rays and 150 Truenat machines to detect disease in asymptomatic individuals across 2,111 high-risk zones....
6 months ago
As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
